Peripherally Inserted Central Catheter Market Overview
As per MRFR analysis, the Peripherally Inserted Central Catheter Market Size was estimated at 3.12 (USD Billion) in 2022.
The Peripherally Inserted Central Catheter Market Industry is expected to grow from 3.24 (USD Billion) in 2023 to 4.5 (USD Billion) by 2032. The Peripherally Inserted Central Catheter Market CAGR (growth rate) is expected to be around 3.72% during the forecast period (2024 - 2032).
Key Peripherally Inserted Central Catheter Market Trends Highlighted
The market of peripherally inserted central catheters (PICC) is experiencing considerable development for a number of reasons, such as the increasing rate of chronic conditions, the growing need for less invasive methods, and improvement in catheter technologies. The rising elderly population, coupled with the modernization of home healthcare facilities, also helps the growth of the market.
Among these factors is the progress in catheter technology, such as antimicrobial coatings and improved insertion techniques, which presents many opportunities to the market players. It is anticipated that more people will embrace the use of PICCs in required situations in a bid to cut down on healthcare-associated infections. Evidence from recent innovations points to the trend of employing ultrasound-assisted PICC positioning in order to improve accuracy and augment care. There is also the aspect of telemedicine as a method of catheter management, which brings forth a new aspect in the growth of the market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Peripherally Inserted Central Catheter Market Drivers
Rising Prevalence of Chronic Diseases
There is a growing prevalence of chronic diseases, such as cancer, kidney disease, and diabetes, across the globe. As a result, there is an increased need for long-term vascular access. PICCs are a viable solution for long-term vascular access because they can be inserted into a peripheral vein and advanced into a central vein. This provides a safe and effective method for ensuring appropriate and reliable access to administering medications, fluids, and blood products.Such measures are expected to increase the utilization of PICCs in the next five years.
Technological Advancements in PICC Design
Technological advancements have led to significant improvements in the design and functionality of PICCs. Newer PICCs are smaller, more flexible, and more durable, making them less likely to cause discomfort or complications. Additionally, the development of antimicrobial PICCs has reduced the risk of infection, which is a major concern with long-term vascular access devices. These technological advancements are expected to further drive the adoption of PICCs in the Peripherally Inserted Central Catheter Market Industry.
Increasing Awareness of PICC Benefits
As more and more healthcare providers and patients are becoming cognizant of the benefits of PICCs, such as the ease of their placement, their low rates of complications, and their cost-effectiveness, their demand is expected to rise, particularly in outpatient settings. Hence, educational programs designed to familiarize the target audience with the advantages of PICCs are anticipated to foster the expansion of the market.
Peripherally Inserted Central Catheter Market Segment Insights
Peripherally Inserted Central Catheter Market Product Type Insights
The Peripherally Inserted Central Catheter Market is segmented by product type into single lumen PICCs, double lumen PICCs, triple lumen PICCs, and multi-lumen PICCs. Among these, single lumen PICCs accounted for the largest revenue share in 2023, and they are expected to maintain their dominance throughout the forecast period. This is primarily due to their widespread use in various clinical settings, including intensive care units, emergency departments, and outpatient clinics. Single lumen PICCs are preferred for short-term use and for administering medications, fluids, and blood products.Double lumen PICCs are the second-largest segment in the Peripherally Inserted Central Catheter Market. They are commonly used for administering multiple medications or fluids simultaneously, as well as for monitoring hemodynamic parameters. Triple lumen PICCs are less common than single and double lumen PICCs, but they offer the advantage of allowing for the simultaneous administration of three different fluids or medications. Key factors driving the growth of the market include the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the growing adoption of home healthcare settings.The market is also expected to benefit from the development of new and innovative PICC technologies, such as antimicrobial PICCs and PICCs with advanced insertion techniques.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Peripherally Inserted Central Catheter Market Material Insights
The Peripherally Inserted Central Catheter Market is segmented based on Material into Polyurethane, Silicone, and Polyethylene Terephthalate . In terms of value, Polyurethane held the largest share in the market in 2023 and is anticipated to grow at a similar rate during the forecast period. High strength, durability, and biocompatibility are the factors to propel the growth of Polyurethane. The demand for the Polyurethane segment will gain a boost during the forecast period with the rapidly increasing use in different applications, including continuous intravenous administration of nutrition, chemotherapy, long-term catheterization, and drug delivery.Silicone segment is anticipated to grow with the highest growth rate during the forecast period owing to the increased usage in long-term urinary catheters. Polyethylene Terephthalate segment is also anticipated to grow at a steady pace attributed to the low cost and ease of processing.
Peripherally Inserted Central Catheter Market Application Insights
The Peripherally Inserted Central Catheter Market is segmented based on application into Long-Term Infusion Therapy, Chemotherapy Administration, Hemodialysis, and Parenteral Nutrition. Among these, Long-Term Infusion Therapy accounts for the largest share of the market. The growing prevalence of chronic diseases, such as cancer and diabetes, which require long-term administration of medications, is driving the demand for peripherally inserted central catheters (PICCs) for long-term infusion therapy. The Peripherally Inserted Central Catheter Market for Long-Term Infusion Therapy is expected to grow at a CAGR of 3.72% from 2024 to 2032, reaching a market size of USD 1.24 billion by 2032.Chemotherapy Administration is another major application segment, owing to the increasing incidence of cancer worldwide. PICCs are commonly used for the administration of chemotherapy drugs, as they provide reliable and long-term vascular access. The Peripherally Inserted Central Catheter Market for Chemotherapy Administration is projected to reach USD 0.98 billion by 2032, exhibiting a CAGR of 3.56% during the forecast period.
Peripherally Inserted Central Catheter Market End User Insights
End User Segmentation The Peripherally Inserted Central Catheter Market is segmented based on end user into hospitals, ambulatory surgical centers, and home healthcare settings. Among these, hospitals are expected to dominate the market, accounting for a significant share of the Peripherally Inserted Central Catheter Market revenue in 2023. The high demand for peripherally inserted central catheters in hospitals can be attributed to the increasing number of complex surgeries, rising prevalence of chronic diseases, and growing demand for minimally invasive procedures.Ambulatory surgical centers are also witnessing a surge in demand for peripherally inserted central catheters due to the increasing number of outpatient surgeries and the preference for less invasive procedures. Home healthcare settings are projected to experience steady growth in the coming years, driven by the growing number of patients with chronic conditions and the increasing adoption of home-based care.
Peripherally Inserted Central Catheter Market Regional Insights
The Peripherally Inserted Central Catheter Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest market share of 38.4% in 2023 and is expected to continue its dominance during the forecast period. The growth in this region can be attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and well-established healthcare infrastructure. Europe accounted for a market share of 32.2% in 2023 and is projected to maintain its position as the second-largest regional market.Factors driving growth in Europe include the growing geriatric population, increasing healthcare expenditure, and technological advancements in the healthcare sector. The APAC region is expected to witness the highest growth rate during the forecast period, owing to the rising healthcare investments, increasing awareness about PICCs, and expanding healthcare infrastructure in countries such as China and India. South America and MEA are expected to contribute a smaller share of the overall market, but they are also expected to experience steady growth due to the increasing demand for PICCs in these regions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Peripherally Inserted Central Catheter Market Key Players And Competitive Insights
Major companies in the Peripherally Inserted Central Catheter Market are focused on introducing new products and expanding their global presence in the Peripherally Inserted Central Catheter Market. Peripherally Inserted Central Catheter Market Leading manufacturers are focusing on strategic partnerships to increase their geographic presence and market shares. The Peripherally Inserted Central Catheter Market Competitive Landscape includes both global multinationals and local companies in the Peripherally Inserted Central Catheter Market. Companies involved in Peripherally Inserted Central Catheter Market development invest heavily in research and development activities to introduce technologically advanced products.
Bard Peripheral Vascular, Inc. is one of the Peripherally Inserted Central Catheter Market’s major companies in the PICC market and focuses on offering innovative vascular access solutions. The company offers a broad range of PICCs, including Groshong PICC, which has highly driven market growth. Groshong PICC is a custom-made Peripherally Inserted Central Catheter Market that focuses on maximizing patient outcomes by reducing complications and optimizing catheter placement. The company’s focus on innovation and customer satisfaction has been beneficial in focusing on the peripherally inserted central caterer market. The company’s focus on product expansion and innovation has granted it a significant market share in the Peripherally Inserted Central Catheter Market.
Medtronic plc is another company in the Peripherally Inserted Central Catheter Market that has acquired a large market share. Medtronic plc is a global medical technology company that produces PICCs such as Melody PICC. Melody PICC has been popular in the market as it is an over-the-wire application requiring the use of a micro-puncture, non-Groshong PICC. In addition, the product is made of polyurethane, which is biocompatible. The introduction of the products, combined with the company’s wide distribution network and strong R&D activities, has made the company predominant.
Key Companies in the Peripherally Inserted Central Catheter Market Include
- Boston Scientific Corporation
- Teleflex Incorporated
- Merit Medical Systems, Inc
- Edwards Lifesciences
- Braun Melsungen AG
- Cardinal Health
- BD
- Terumo Medical Corporation
- Vygon
- Smiths Medical
- Medtronic
- Cook Medical
- AngioDynamics
- ICU Medical
- Fresenius Kabi
Peripherally Inserted Central Catheter Market Industry Developments
The global Peripherally Inserted Central Catheter (PICC) market size was valued at USD 3.24 billion in 2023 and is projected to grow at a CAGR of 3.72% from 2024 to 2032. The increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and growing adoption of PICCs in home healthcare settings are driving the market growth. The introduction of advanced PICC technologies, such as antimicrobial coatings and ultrasound-guided insertions, is further contributing to market expansion. Key industry players are focusing on strategic partnerships, product innovations, and geographic expansions to gain a competitive edge. Recent news developments include the launch of new PICC products with enhanced features and the acquisition of smaller companies by larger market players to strengthen their product portfolios.
Peripherally Inserted Central Catheter Market Segmentation Insights
-
Peripherally Inserted Central Catheter Market Product Type Outlook
- Single Lumen PICCs
- Double Lumen PICCs
- Triple Lumen PICCs
- Multi-lumen PICCs
-
Peripherally Inserted Central Catheter Market Material Outlook
- Polyurethane
- Silicone
- Polyethylene Terephthalate (PET)
-
Peripherally Inserted Central Catheter Market Application Outlook
- Long-Term Infusion Therapy
- Chemotherapy Administration
- Hemodialysis
- Parenteral Nutrition
-
Peripherally Inserted Central Catheter Market End User Outlook
- Hospitals
- Ambulatory Surgical Centers
- Home Healthcare Settings
-
Peripherally Inserted Central Catheter Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
Report Attribute/Metric |
Details |
Market Size 2022 |
3.12(USD Billion) |
Market Size 2023 |
3.24(USD Billion) |
Market Size 2032 |
4.5(USD Billion) |
Compound Annual Growth Rate (CAGR) |
3.72% (2024 - 2032) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Base Year |
2023 |
Market Forecast Period |
2024 - 2032 |
Historical Data |
2019 - 2023 |
Market Forecast Units |
USD Billion |
Key Companies Profiled |
Boston Scientific Corporation, Teleflex Incorporated, Merit Medical Systems, Inc, Edwards Lifesciences, B. Braun Melsungen AG, Cardinal Health, BD, Terumo Medical Corporation, Vygon, Smiths Medical, Medtronic, Cook Medical, AngioDynamics, ICU Medical, Fresenius Kabi |
Segments Covered |
Product Type, Material, Application, End User, Regional |
Key Market Opportunities |
Growing demand for PICCs in critical care home healthcare and oncology Technological advancements in PICC design and materials Increasing prevalence of chronic diseases and associated infections Favorable reimbursement policies for PICCs in developed countries Expansion of PICC use in developing regions |
Key Market Dynamics |
Increasing demand for minimally invasive procedures Technological advancements Growing geriatric population Rising prevalence of chronic diseases Expanding applications in emergency and critical care |
Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Peripherally Inserted Central Catheter Market is expected to reach a valuation of USD 4.5 billion by 2032, exhibiting a CAGR of 3.72% during the forecast period (2024-2032).
North America is expected to maintain its dominance in the Peripherally Inserted Central Catheter Market, accounting for a significant share throughout the forecast period.
Rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and technological advancements are the primary factors driving the growth of the Peripherally Inserted Central Catheter Market.
The oncology segment is projected to a significant share in the Peripherally Inserted Central Catheter Market due to the rising incidence of cancer and the need for long-term vascular access for chemotherapy and other treatments.
Key competitors in the Peripherally Inserted Central Catheter Market include BD, Teleflex, Cook Medical, Medtronic, and B. Braun Melsungen.
Miniaturization of devices, development of antimicrobial catheters, and the integration of advanced technologies such as AI and IoT are shaping the future of the Peripherally Inserted Central Catheter Market.
The Peripherally Inserted Central Catheter Market is projected to expand at a CAGR of 3.72% from 2024 to 2032.
The Asia Pacific region is anticipated to exhibit the highest growth rate in the Peripherally Inserted Central Catheter Market due to increasing healthcare expenditure, rising awareness, and expanding healthcare infrastructure.
Complications associated with PICC insertion and maintenance, reimbursement issues, and the availability of alternative vascular access devices pose challenges to the growth of the Peripherally Inserted Central Catheter Market.
Technological advancements, increasing demand for home healthcare, and the introduction of new products and applications present significant growth opportunities for the Peripherally Inserted Central Catheter Market.